Výsledky vyhledávání - "Agnes LF Chan"

Akademický článek

Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer

Autor: John Hang Leung, Yun-sheng Tai, Shyh-Yau Wang, Hei-Tung Yip Fion, Ho Tsung-chin, Agnes LF. Chan

Publikováno v: Breast, Vol 65, Iss , Pp 91-97 (2022)

Background: The rising cost of cancer drug therapy threatens the long-term sustainability of Taiwan National Health Insurance. Cost savings can be achieved through various strategies, e.g., using smaller vial sizes, sharing vials, weight-based dosing

Externí odkaz: https://doaj.org/article/899dc4b0aa97488399abab1c7735a21e

Zobrazit plný text záznamu

Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis

Autor: John Hang, Leung, Yun-Sheng, Tai, Shyh-Yau, Wang, Ho, Tsung-Chin, Hei-Tung, Yip Fion, Agnes Lf, Chan, Hsu, Yu-Chen

Publikováno v: Expert Opinion on Drug Safety. 22:243-252

Several therapies directed at novel targets and also immunotherapies have recently shown promising results in advanced or metastatic TNBC. We aimed to compare the efficacy and safety of these new regimens for advanced or metastatic TNBC (mTNBC).The P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbef87bab7bd4896b668c111e8df2a54
https://doi.org/10.1080/14740338.2022.2116001

Zobrazit plný text záznamu

Cost–effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan

Autor: John Hang Leung, Chih-Wen Chang, Agnes LF Chan, Hui-Chu Lang

Publikováno v: Future Oncology. 18:859-870

Objectives: To evaluate the cost–effectiveness of immune checkpoint inhibitors versus docetaxel in patients with advanced non-small-cell lung cancer. Methods: A Markov model was constructed to simulate the clinical outcomes and costs of advanced no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4716809eaa235b36aca5b159fc0ba6c
https://doi.org/10.2217/fon-2021-0785

Zobrazit plný text záznamu

Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer

Autor: John Hang Leung, Yun-sheng Tai, Shyh-Yau Wang, Hei-Tung Yip Fion, Ho Tsung-chin, Agnes LF. Chan

Publikováno v: Breast (Edinburgh, Scotland). 65

The rising cost of cancer drug therapy threatens the long-term sustainability of Taiwan National Health Insurance. Cost savings can be achieved through various strategies, e.g., using smaller vial sizes, sharing vials, weight-based dosing, or switchi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2444e0f162f4477920ba2b6563eac51c
https://pubmed.ncbi.nlm.nih.gov/35870421

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání